BBIO
BridgeBio Pharma Inc
$73.47
2.47 (3.43%) Today
1.01 (1.36%) After-hours
— up— down
Market Cap
$14.59B+72.5%
Revenue (TTM)
$583.15M+355.2%
Net Income (TTM)
$-733,652,388
$-733,652,388EPS (TTM)
-3.75
-3.75Shares Out
195.86M
195.86MOpen
$72.46
$72.46Previous Close
$72.01
$72.01Day Range
$71.78 – $74.65
$71.78 – $74.6552-Week Range
$41.80 – $84.94
$41.80 – $84.94Beta
0.96
0.96Volume
3.39M
3.39MAvg Volume
2.90M
2.90MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout BBIO
Related
News
BridgeBio: 3 New Drug Approvals In Sight Outweigh Attruby Issues, Still Bullish
SeekingAlpha · 1d ago
Reported Sunday, BridgeBio PROPEL 3 Phase 3 Trial Published In NEJM, Oral Infigratinib Demonstrates Statistically Significant Improvements In Height, Body Proportionality In Achondroplasia
Benzinga · 1d ago